Centivax
Latest round
- Series A
Last raised
- Jul 2025
Total raised
- $55M
Investors
- 7
About Centivax
Founded in 2020 and based in California, US, Centivax, Inc. operates as a biotechnology company that focuses on the research and development of vaccines. In March 2026, Centivax, Inc. Centivax's portfolio includes broad-spectrum vaccines to treat infectious diseases like the flu and COVID, broad-spectrum anti-infectives, and broad-spectrum snake anti-venom. The portfolio first targets the three rapidly mutating pathogens responsible for the most infections and deaths in humans: seasonal and pandemic influenza viruses(flu), coronaviruses (COVID-19), and HIV(AIDS). Additionally, Centivax’s platform is designed to teach the immune system to target critical regions of viral spike proteins that the viruses are not able to mutate. The technology platform is compatible with, and IP covers, major vaccine delivery technologies including well-established recombinant protein-based vaccines, VLPs, and recent mRNA platforms.
Who invested in Centivax
7 investors across 2 rounds
See all investors in Centivax
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Centivax
Who invested in Centivax?
Centivax has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Centivax raised?
Centivax has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Centivax last raise money?
Centivax's most recent round on record is a Series A, in Jul 2025.
What does Centivax do?
Founded in 2020 and based in California, US, Centivax, Inc.
Where is Centivax headquartered?
Centivax is headquartered in South San Francisco, US.
Which VCs invest in companies like Centivax?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Centivax's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Centivax? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.